Tumor Response Rate
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| TILA-TACE in Treatment of Hepatocellular Carcinoma (NCT03910140) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2017-11-01 |
Track Tumor Response Rate automatically
Every clearance here is in the API, with alerts when new ones post.